4-Butylamino-1-cyclohexyloxy-2,2,6,6-tetramethylpiperidine → 1-Cyclohexyloxy-2,2,6,6-tetramethyl-1,2,3,6-tetrahydro-pyridine

HRID 448534

반응식

HRID 448534 반응식
C(N[CH:6]1[CH2:11][C:10]([CH3:13])([CH3:12])[N:9]([O:14][CH:15]2[CH2:20][CH2:19][CH2:18][CH2:17][CH2:16]2)[C:8]([CH3:22])([CH3:21])[CH2:7]1)CCC>[Pd].CO>[CH:15]1([O:14][N:9]2[C:8]([CH3:22])([CH3:21])[CH:7]=[CH:6][CH2:11][C:10]2([CH3:13])[CH3:12])[CH2:20][CH2:19][CH2:18][CH2:17][CH2:16]1

참가 물질

4

반응물 1

HCID 211821294-Butylamino-1-cyclohexyloxy-2,2,6,6-tetramethylpiperidine

생성물 1

HCID 574651861-Cyclohexyloxy-2,2,6,6-tetramethyl-1,2,3,6-tetrahydro-pyridine

시약·촉매·용매 2

HCID 23938Palladium촉매HCID 887Methanol용매

실험 절차

Hydrogenation at this stage (MeOH, 5% Pd/C, 5 bar H2, 40° C.) leads to butyl-(1-cyclohexyloxy-2,2,6,6-tetramethyl-piperidin-4-yl)-amine, compound D.

출처 및 근거

ORD 기록
ord-043308aa0dd744cb9cb7c7cf7e004136
출처 데이터셋
uspto-grants-2013_07
특허 번호
US08481726B2

연결된 노트

불러오는 중…